The Aurinia Pharmaceuticals (AUPH) - Investment Analysts' Weekly Ratings Changes

A stock chart showing declines drawn on a chalkboard with a businessman looking

A stock chart showing declines drawn on a chalkboard with a businessman looking

This rating was issued on 11/01/16. The stock's price fluctuated within the range of $7.51 - $8.33 during previous trading session.

Price Target is basically a projection of future price of a company's stock by the expert analysis of investment analysts or investment firms. A higher price target would definitely provide confidence to investors during the trading action, consideration given by Wall Street Journal.

Following analysis criteria, Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has the market capitalization of $301.43 Million. (NASDAQ:AUPH) to Buy with no specific Price Target on 6/30/16.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) now has a consensus Price Target of $10.3.

Many analysts have provided their estimated foresights on Aurinia Pharmaceuticals Inc.

According to TipRanks.com, which ranks over 7,500 financial analysts and bloggers to gauge the performance of their past recommendations, Vernon Bernardino and John Newman have a yearly average loss of 6.8% and 4.9% respectively.

In terms of Buy/Sell recommendations, analysts have a consensus rating of 1.00 on the shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH).

In the last Quarter, Aurinia Pharmaceuticals Inc. These analysts have also projected a Low Estimate of $-0.14/share and a High Estimate of $-0.1/share.

Many Analysts provided their foresight on Revenue Estimates of Aurinia Pharmaceuticals Inc. where they believe that the company has the potential to earn average revenue of $80 Million for the current quarter.

To take look on ration of tradable shares being shorted in market, float short ration was 14.84%, as compared to sentiment indicator; Short Ratio was 0.70. This shows a surprise factor of -83.3%. Redmile Group LLC now owns 187,610 shares of the company's stock valued at $565,000 after buying an additional 159,200 shares during the last quarter.

Aurinia Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company has a 1 Year high price target of $10.3. Current stock price is in the upbeat territory taking into account of 20 days moving average with 129.43% and continued bullish run for 50 days moving average with 205.63%.

Currently, the company has SMA200 (200-day simple moving average) of 180.36 Percent.

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) is now showing its ROA (Return on Assets) of 0%. The Return on Assets stands at 0%, Return on Equity shows 0% and Return on Investment value is 0%. The average twelve-month target price among brokerages that have updated their coverage on the stock in the previous year is $10.00. During the twelve month it added 300.76% and year to date performance of 401.90%.

Relative strength index (RSI-14) for Aurinia Pharmaceuticals Inc.

Shares in Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) inclined 1.75%, trading current session at $1.16 with a total trading volume of 1.18 million shares.

The Company now has Insider ownership of 0 Percent and Institutional Ownership of 0 Percent. AUPH has P/E (Price to Earnings ttm) value of 0, Forward P/E of 0, P/C (Price to cash per share) of 0 and Price to Free Cash Flow (P/FCF) value of 0.

The stock is now showing YTD performance of 270 Percent.

Recommended News

  • Real estate worth $121 billion to benefit from REIT opportunity in India

    Real estate worth $121 billion to benefit from REIT opportunity in India

    The Company's business consists of the ownership and operation of real property in the greater Washington metro region. The 52 week high of Real Estate Investors PLC's shares is 64.9 whilst the 52 week low for shares in the company is 50.
    One Stock Analysts Are Watching - Sirius XM Holdings Inc. (NASDAQ:SIRI)

    One Stock Analysts Are Watching - Sirius XM Holdings Inc. (NASDAQ:SIRI)

    For SIRI, the company now has $213.94 Million of cash on the books, which is offset by $5.49 Million current liabilities. Biegel & Waller LLC acquired a new position in Sirius XM Holdings during the fourth quarter valued at $101,000.
    Charlotte Crosby Opens Up About Her Rare Breast Condition, 'Uniboob'

    Charlotte Crosby Opens Up About Her Rare Breast Condition, 'Uniboob'

    To make matters worse the reality star wasn't alone in bed and her boyfriend, Stephen Bear also had to deal with Char's accident. Charlotte and Bear are now on holiday together - and have discussed their plans to marry and start a family in recent weeks.
  • Phil Spencer Teases Popular Game Will Soon Be Xbox One Backwards Compatible

    Spencer responded by saying that Xbox usage for buying games and DLCs are high, while the console's attach rate is also high. Call of Duty: Black Ops 2 is the most requested game, although it sounds like it won't be on the list yet.
    Cracker Barrel Fires Brad's Wife After 11 Years, Internet EXPLODES

    Cracker Barrel Fires Brad's Wife After 11 Years, Internet EXPLODES

    Calling his wife a good person, Byrd said that it saddened him that his wife was hurt by being fired from Cracker Barrel. Someone even changed the Cracker Barrel Wikipedia entry to read, "Number of employees: 70,000, minus Brad's wife".
    Barclays Capital Issues Price Target With 20.26% Upside On Hunting PLC

    Barclays Capital Issues Price Target With 20.26% Upside On Hunting PLC

    The stock was acquired at an average cost of GBX 6,798 ($83.96) per share, with a total value of £10,061.04 ($12,425.64). The 52 week high shares of esure Group plc have reached is 311 whilst the 52 week low for the company's shares is 183.1.
  • Park Hotels & Resorts Inc (PK) To Go Ex-Dividend on March 29th

    Comparatively, Host Hotels & Resorts, Inc. posted earnings of $0.39 per share in the same quarter a year ago . (HST) is at 46.48. Sarasin & Partners LLP boosted its stake in shares of Host Hotels and Resorts by 1.1% in the third quarter.
    Next Weeks Broker Price Targets For Concordia Healthcare Corp. (NASDAQ:CXRX)

    Next Weeks Broker Price Targets For Concordia Healthcare Corp. (NASDAQ:CXRX)

    Concordia International Corp has a 52 week low of $1.69 and a 52 week high of $34.52 The company's market cap is now $0. A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the company.
    Financial Advisers Get DOL Guidance on Fiduciary Rule Delay

    Financial Advisers Get DOL Guidance on Fiduciary Rule Delay

    We've covered this regulation for nearly seven years, and we think advisers deserve better than the perpetual runaround. No one likes being regulated, and no one likes being taken advantage of.
  • Bridges of Madison County author Robert James Waller dies, 77

    Bridges of Madison County author Robert James Waller dies, 77

    Waller will be greatly missed. "It all just came pouring out", he told New York Daily News. "I am open to rational discussion". Other books in his bibliography include: " Slow Waltz in Cedar Bend ", " Puerto Vallarta Squeeze " and " Border Music ".
    The Bachelor 2017: How Long Will Nick and Vanessa Last?

    The Bachelor 2017: How Long Will Nick and Vanessa Last?

    He's got a shot mostly just because he's relatively recent, and he may be memorable to some semi-casual fans of the franchise. Nick Viall absolutely loved the 3.75 carat ring he picked out for Vanessa Grimaldi, but he wasn't the first to choose it.
    Woman who fought off attacker fights back against political campaign

    Woman who fought off attacker fights back against political campaign

    Herron said self-defense lessons saved her, as she fought back with tactics she had just learned three weeks earlier. Eventually, she made it out of the bathroom and was able to lock him inside with help from a person passing by.

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.